GENB

Announcements

Nothing here yet

Daily updates

• Generate Biomedicines initiated two global Phase 3 trials for GB-0895 in severe asthmaAug 27, 2026

FDA designations

Nothing here yet

News

• Generate Biomedicines and Zealand Pharma enter a collaboration and licensing agreement to develop AI-engineered protein therapeutics for metabolic diseasesOct 14, 2026
• Roswell Park and Generate Biomedicines launch an exclusive clinical trial of an armored CAR T therapy for ovarian cancerOct 1, 2026